NEXIEN BIOPHARMA, INC. Business Finance Contracts & Agreements

14 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Convertible Promissory Note dated October 3, 2024 issued to Quick Capital, LLC
Note Agreements
NEXIEN BIOPHARMA, INC.
Pharmaceuticals
2024
Note Purchase Agreement dated October 3, 2024 between the Company and Quick Capital, LLC
Note Agreements
NEXIEN BIOPHARMA, INC.
Pharmaceuticals
2024
Convertible Promissory Note dated February 14, 2024 issued to Quick Capital, LLC
Note Agreements
NEXIEN BIOPHARMA, INC.
Pharmaceuticals
FL
2024
Note Purchase Agreement dated February 14, 2024 between the Company and Quick Capital, LLC
Note Agreements
NEXIEN BIOPHARMA, INC.
Pharmaceuticals
2024
Amendment and Extension of Note Purchase Agreement dated May 8, 2023
Note Agreements
NEXIEN BIOPHARMA, INC.
Pharmaceuticals
2023
Common Stock Purchase Warrant dated January 18, 2022 issued to Quick Capital, LLC
Warrant Agreements
NEXIEN BIOPHARMA, INC.
Pharmaceuticals
FL
2022
Convertible Promissory Note dated January 18, 2022 issued to Quick Capital, LLC
Note Agreements
NEXIEN BIOPHARMA, INC.
Pharmaceuticals
FL
2022
Note Purchase Agreement dated January 18, 2022 between the Company and Quick Capital, LLC
Note Agreements
NEXIEN BIOPHARMA, INC.
Pharmaceuticals
2022
Convertible Promissory Note and Warrants dated November 24, 2020 to Richard Greenberg
Note Agreements
NEXIEN BIOPHARMA, INC.
Pharmaceuticals
2021
Demand Convertible Promissory Note dated June 11, 2020 to Richard Greenberg
Note Agreements
NEXIEN BIOPHARMA, INC.
Pharmaceuticals
2020
Limited Liability Company Interest Purchase Agreement by and among the Members of CRX Bio Holdings LLC and Nexien BioPharma, Inc. dated October 26, 2018
Purchase Agreements
NEXIEN BIOPHARMA, INC.
Pharmaceuticals
CO
2018
Form of Class E Warrant
Warrant Agreements
NEXIEN BIOPHARMA, INC.
Pharmaceuticals
2018
Form of Class D Warrant
Warrant Agreements
NEXIEN BIOPHARMA, INC.
Pharmaceuticals
2018
Amended and Restated Share Exchange Agreement between the Registrant and Intiva BioPharma Inc., dated October 13, 2017
Exchange Agreements
NEXIEN BIOPHARMA, INC.
Pharmaceuticals
NY
2017